Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial

IMPORTANCE: Trifluridine/tipiracil (FTD/TPI) treatment has shown clinical benefit in patients with pretreated metastatic gastric cancer or gastroesophageal junction cancer (mGC/GEJC). Patients who have undergone gastrectomy constitute a significant proportion of patients with mGC/GEJC. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilson, David H., Tabernero, Josep, Prokharau, Aliaksandr, Arkenau, Hendrik-Tobias, Ghidini, Michele, Fujitani, Kazumasa, Van Cutsem, Eric, Thuss-Patience, Peter, Beretta, Giordano D., Mansoor, Wasat, Zhavrid, Edvard, Alsina, Maria, George, Ben, Catenacci, Daniel, McGuigan, Sandra, Makris, Lukas, Doi, Toshihiko, Shitara, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802061/
https://www.ncbi.nlm.nih.gov/pubmed/31600365
http://dx.doi.org/10.1001/jamaoncol.2019.3531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802061/
https://www.ncbi.nlm.nih.gov/pubmed/31600365
http://dx.doi.org/10.1001/jamaoncol.2019.3531

Ejemplares similares